Insights Into Cardiovascular Risks of Chimeric Antigen Receptor T-Cell Therapy-From Peril to Promise
- PMID: 39374023
- DOI: 10.1001/jamanetworkopen.2024.37157
Insights Into Cardiovascular Risks of Chimeric Antigen Receptor T-Cell Therapy-From Peril to Promise
Comment on
-
Cardiovascular Events After Chimeric Antigen Receptor T-Cell Therapy for Advanced Hematologic Malignant Neoplasms: A Meta-Analysis.JAMA Netw Open. 2024 Oct 1;7(10):e2437222. doi: 10.1001/jamanetworkopen.2024.37222. JAMA Netw Open. 2024. PMID: 39374017 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources